The child is father to the man: Developmental roles for proteins of importance for neurodegenerative disease

Annals of Neurology

Volumn 67, Issue 2, 2010, Pages 151-158

  Rogers, Danny ^a   Schor, Nina F ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN DERIVATIVE;

ALZHEIMER DISEASE; APOPTOSIS; CELL MIGRATION; DEGENERATIVE DISEASE; HUMAN; NERVE CELL DIFFERENTIATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW;

HUMANS; MALE; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; PROTEINS;

EID: 77949344973     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21841     Document Type: Review

References (49)

1. Zhu X, Raina AK, Perry G, Smith MA. Alzheimer's disease: the two-hit hypothesis. Lancet Neurol 2004;3:219-226.
2. Lim KL, Chew KC, Tan JM, et al. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. J Neurosci 2005;25:2002-2009.
3. Zhu X, Lee HG, Perry G, Smith MA. Alzheimer disease, the two-hit hypothesis: an update. Biochim Biophys Acta 2007;1772: 494-502.
4. Yang Y, Herrup K. Cell division in the CNS: protective response or lethal event in post-mitotic neurons? Biochim Biophys Acta 2007;1772:457-466.
5. Reiner O, Shmueli A, Sapir T. Neuronal migration and neurodegeneration: 2 sides of the same coin. Cereb Cortex 2009;19:142-148.
6. Steiner H, Fluhrer R, Haass C. Intramembrane proteolysis by gamma-secretase. J Biol Chem 2008;283:29627-29631.
7. Lasky JL, Wu H. Notch signaling, brain development, and human disease. Pediatr Res 2005;57:104R-109R.
8. Salehi A, Ocampo M, Verhaagen J, Swaab DF. P75 neurotrophin receptor in the nucleus basalis of Meynert in relation to age, sex, and Alzheimer's disease. Exp Neurol 2000;161:245-258.
9. Jung KM, Tan S, Landman N, et al. Regulated intramembrane proteolysis of the p75 neurotrophin receptor modulates its association with the TrkA receptor. J Biol Chem 2003;278: 42161-42169.
10. Deppmann CD, Mihalas S, Sharma N, et al. A model for neuronal competition during development. Science 2008;320:369-373.
11. Hamanoue M, Middleton G, Wyatt S, et al. p75-mediated NF-kappaB activation enhances the survival response of developing sensory neurons to nerve growth factor. Mol Cell Neurosci 1999; 14:28-40.
12. Tyurina YY, Nylander KD, Mirnics ZK, et al. The intracellular domain of p75NTR as a determinant of cellular reducing potential and response to oxidant stress. Aging Cell 2005;4:187-196.
13. Bredesen DE, Mehlen P, Rabizadeh S. Apoptosis and dependence receptors: a molecular basis for cellular addiction. Physiol Rev 2004;84:411-430.
14. Yan Ch, Mirnics ZK, Portugal CF, et al. Cholesterol biosynthesis and the pro-apoptotic effects of the p75 nerve growth factor receptor in PC12 pheochromocytoma cells. Brain Res Mol Brain Res 2005;139:225-234.
15. Korade Z, Mi Z, Portugal CF, Schor NF. Expression and p75 neurotrophin receptor dependence of cholesterol synthetic enzymes in adult mouse brain. Neurobiol Aging 2007;28:1522-1531.
16. Wakabayashi T, De Strooper B. Presenilins: members of the gamma-secretase quartets, but part-time soloists too. Physiology (Bethesda, Md) 2008;23:194-204.
17. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
18. Jiang Q, Lee CY, Mandrekar S, et al. ApoE promotes the proteolytic degradation of Abeta. Neuron 2008;58:681-693.
19. D'Arcangelo G, Homayouni R, Keshvara L, et al. Reelin is a ligand for lipoprotein receptors. Neuron 1999;24:471-479.
20. D'Arcangelo G, Curran T. Reeler: new tales on an old mutant mouse. Bioessays 1998;20:235-244.
21. Park TJ, Curran T. Crk and Crk-like play essential overlapping roles downstream of disabled-1 in the Reelin pathway. J Neurosci 2008;28:13551-13562.
22. Hashimoto-Torii K, Torii M, Sarkisian MR, et al. Interaction between Reelin and Notch signaling regulates neuronal migration in the cerebral cortex. Neuron 2008;60:273-284.
23. Borrell V, Pujadas L, Simó S, et al. Reelin and mDab1 regulate the development of hippocampal connections. Mol Cell Neurosci 2007;36:158-173.
24. Ozcelik T, Akarsu N, Uz E, et al. Mutations in the very lowdensity lipoprotein receptor VLDLR cause cerebellar hypoplasia and quadrupedal locomotion in humans. Proc Natl Acad Sci USA 2008;105:4232-4236.
25. Merdes G, Soba P, Loewer A, et al. Interference of human and Drosophila APP and APP-like proteins with PNS development in Drosophila. EMBO J 2004;23:4082-4095.
26. Pramatarova A, Ochalski PG, Lee CH, Howell BW. Mouse disabled 1 regulates the nuclear position of neurons in a Drosophila eye model. Mol Cell Biol 2006;26:1510-1517.
27. Hoareau C, Borrell V, Soriano E, et al. Amyloid precursor protein cytoplasmic domain antagonizes reelin neurite outgrowth inhibition of hippocampal neurons. Neurobiol Aging 2008;29:542-553.
28. Pramatarova A, Chen K, Howell BW. A genetic interaction between the APP and Dab1 genes influences brain development. Mol Cell Neurosci 2008;37:178-186.
29. Iwai A, Masliah E, Yoshimoto M, et al. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 1995;14: 467-475.
30. Raghavan R, Kruijff L, Sterrenburg MD, et al. Alpha-Synuclein expression in the developing human brain. Pediatr Dev Pathol 2004;7:506-516.
31. Outeiro TF, Lindquist S. Yeast cells provide insight into alpha-Synuclein biology and pathobiology. Science 2003;302: 1772-1775.
32. Abeliovich A, Schmitz Y, Fariñas I, et al. Mice lacking alpha-Synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 2000;25:239-252.
33. Lee FJ, Liu F, Pristupa ZB, Niznik HB. Direct binding and functional coupling of alpha-Synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. FASEB J 2001;15:916-926.
34. Schneider BL, Seehus CR, Capowski EE, et al. Over-expression of alpha-Synuclein in human neural progenitors leads to specific changes in fate and differentiation. 2007;16:651-666.
35. Mukhopadhyay D, Riezman H. Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science 2007;315: 201-205.
36. Xiong H, Wang D, Chen L, et al. Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. J Clin Invest 2009;119:650-660.
37. Palacino JJ, Sagi D, Goldberg MS, et al. Mitochondrial dysfunction and oxidative damage in Parkin-deficient mice. J Biol Chem 2004;279:18614-18622.
38. Fallon L, Bélanger CM, Corera AT, et al. A regulated interaction with the UIM protein Eps15 implicates Parkin in EGF receptor trafficking and PI(3)K-Akt signalling. Nat Cell Biol 2006;8: 834-842.
39. Mi Z, Rogers D, Mirnics ZK, Schor NF. p75NTR modulation of cellular handling of reactive oxygen species. J Neurochem 2009; 110:296-306.
40. Galter D, Westerlund M, Belin AC, Olson L. DJ-1 and UCH-L1 gene activity patterns in the brains of controls, Parkinson and schizophrenia patients and in rodents. Physiol Behav 2007;92:46-53.
41. Liu Y, Fallon L, Lashuel HA, et al. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-Synuclein degradation and Parkinson's disease susceptibility. Cell 2002;111: 209-218.
42. Sakurai M, Ayukawa K, Setsuie R, et al. Ubiquitin C-terminal hydrolase L1 regulates the morphology of neural progenitor cells and modulates their differentiation. J Cell Sci 2006;119:162-171.
43. Exner N, Treske B, Paquet D, et al. Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by Parkin. J Neurosci 2007;27:12413-12418.
44. Canet-Avilés RM, Wilson MA, Miller DW, et al. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci USA 2004;101:9103-9108.
45. Vasseur S, Afzal S, Tardivel-Lacombe J, et al. DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses. Proc Natl Acad Sci USA 2009;106:1111-1116.
46. Mata IF, Wedemeyer WJ, Farrer MJ, et al. LRRK2 in Parkinson's disease: protein domains and functional insights. Trends Neurosci 2006;29:286-293.
47. Westerlund M, Belin AC, Anvret A, et al. Developmental regulation of leucine-rich repeat kinase 1 and 2 expression in the brain and other rodent and human organs: implications for Parkinson's disease. Neuroscience 2008;152:429-436.
48. Hä big K, Walter M, Poths S, et al. RNA interference of LRRK2-microarray expression analysis of a Parkinson's disease key player. Neurogenetics 2008;9:83-94.
49. Imai Y, Gehrke S, Wang HQ, et al. Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO J 2008;27:2432-2443.